ctDNA-guided Treatment Decision-making

Clinical trial NCT07394218 · RECRUITING

Trial details

NCT number: NCT07394218
Sponsor: Fudan University
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Metastatic Breast Cancer ( HER2 Negative)ctDNA

Start date: 2025-12-24
Primary completion: 2028-03-31
Enrollment: 122

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.